Figure 4

Inhibition of human DLBCL tumor nodule growth by tk-VLPs in a xenograft mouse model. The human DLBCL–xenografted mice were intravenously administered control VLPs or tk-VLPs in the presence or absence of GCV. (A) Gross pictures of tumor nodules from each treatment group. (B) Quantification of tumor weights for the different treatment groups. *, P < 0.05.